Use access key #2 to skip to page content.
$16.76 0.70 (4.36%)
7/3/2008 1:00 PM

Omrix Biopharmaceuticals, Inc. (OMRI)

CAPS Rating:
****

A commercial-stage biopharmaceutical company that develops and markets innovative biological products.

View All Commentary (OMRI)

Recs

0

Avatar richardrogers4 (44.79) Submitted: 5/14/08 5:00 PM : Outperform Start Price: $15.16 OMRI Score: 21.09

RB Pick

Report this Post Replies: 0 | Reply

Featured Broker Partners